The Valley Desk

ArticleJournal of nuclear medicine : official publication, Society of Nuclear MedicinePublished

Phase 1 Dose-Escalation Study of the Rapid-Clearance Radioligand [177Lu]Lu-P17-087 in Metastatic Castration-Resistant Prostate Cancer: Dosimetry, Safety, and Preliminary Efficacy

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published
Subject terms
Dose Escalation; Metastatic Castration-resistant Prostate Cancer; Psma; Radiopharmaceutical Therapy; Mcrpc; P17-087
PubMed ID
42785946
Added to directory
Source checked

Report a correction or request removal